본문 바로가기

전체 글

 (819)
Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder Market  In the 7MM, the total prevalent population of Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder was estimated to be 16,397 cases in 2017. The market size of Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder in the seven major markets was found to be USD 5.95 Million in 2017 and is expected to grow during the study period (2017–2030). The key factors such as understanding molecu..
Sciatica Market Analysis The total prevalent population of Sciatica in the seven major markets was 27,022,660 in 2017. In 2017, the market size of Sciatica in the 7MM was found to be USD 2,047.28 Million and is expected to grow during the study period (2017–2030). Factors such as survival rate, improved awareness, efficient pipeline activity, increased research and development are expected to drive the Sciatica market f..
Small Cell Lung Cancer Market Analsyis Small cell lung cancer can affect all the age groups; however, middle-aged and older adults are observed to be affected more as compared to other age groups. A gender gap can also be witnessed with a higher male Small Cell Lung Cancer incidence than females in the seven major markets. As per DelveInsight, approximately 55% of the Small Cell Lung Cancer diagnosed pool consisted of males; however,..
Top 5 Deadliest Cancers Over the past few decades Cancer has emerged as a major public health concern worldwide. Globally, cancer is ranked second in terms of the number of deaths that take place in a year. Almost a sixth death worldwide is due to cancer, and as per the estimates around 9.6 million deaths occur in 2018 due to it. Cancer severely affects lives and causes a hugely impact on the economy in terms of expend..
PD-L1 NSCLC Market Analysis The total cases of Programmed Death-Ligand 1 (PD-L1) mutated Non-small Cell Lung Cancer (NSCLC) in the 7MM were observed to be 242,014 in 2017. The therapeutic market size of Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC) in seven major markets was found to be USD 6,536 million in 2017 which is expected to increase during the study period (2017–2030). Increasing use of biom..
Duchenne Muscular Dystrophy Treatment Market Size The total diagnosed Duchenne Muscular Dystrophy prevalent population in the seven major makrets was found to be 27,685 in 2017. As per DelveInsight, Duchenne Muscular Dystrophy Market is anticipated to grow promisingly well from USD 266.06 Million as estimated in 2017 for the study period of 2017-30. The launch of emerging therapies in the Duchenne Muscular Dystrophy Pipeline, mostly which are i..
Lambert-Eaton Myasthenic Syndrome (LEMS) Market Size and Share The total prevalent population of Lambert-Eaton Myasthenic Syndrome in the 7MM was found to be 5,977 in 2017. While, the prevalence of LEMS in the United States was 3,255 during the same period. The therapeutic market of LEMS in the seven major markets was assessed to be USD 59.43 million in 2017 and is expected to grow during the study period (2017–2030). Development of a new diagnostic approac..
Geographic Atrophy Market Size and Share The total diagnosed cases of Geographic Atrophy in the 7MM were found to be 2,516,401 in 2017. The market size of Geographic Atrophy in 7MM was USD 276 Million in 2017, which is expected to grow during the study period, i.e., 2017–2030. Increasing prevalence rate, emerging novel treatment options, and patient-friendly dosage regimes are some of the key factors expected to drive the Geographic At..

티스토리툴바